标题/作者	年份
Interleukin-17A and keratinocytes in psoriasis M Furue, K Furue, G Tsuji, T Nakahara International journal of molecular sciences 21 (4), 1275	2020
Extracellular signal-regulated kinase: a regulator of cell growth, inflammation, chondrocyte and bone cell receptor-mediated gene expression N Lu, CJ Malemud International journal of molecular sciences 20 (15), 3792	2019
Efficacy and safety of continuous risankizumab therapy vs treatment withdrawal in patients with moderate to severe plaque psoriasis: a phase 3 randomized clinical trial A Blauvelt, CL Leonardi, M Gooderham, KA Papp, S Philipp, JJ Wu, ... JAMA dermatology 156 (6), 649-658	2020
JAK inhibitors for treatment of psoriasis: focus on selective TYK2 inhibitors M Nogueira, L Puig, T Torres Drugs 80 (4), 341-352	2020
IL-12 family cytokines in cancer and immunotherapy B Mirlekar, Y Pylayeva-Gupta Cancers 13 (2), 167	2021
Bimekizumab versus adalimumab in plaque psoriasis RB Warren, A Blauvelt, J Bagel, KA Papp, P Yamauchi, A Armstrong, ... New England Journal of Medicine 385 (2), 130-141	2021
IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis JG Krueger, KA Wharton Jr, T Schlitt, M Suprun, RI Torene, X Jiang, ... Journal of Allergy and Clinical Immunology 144 (3), 750-763	2019
Apoptotic or antiproliferative activity of natural products against keratinocytes for the treatment of psoriasis TH Huang, CF Lin, A Alalaiwe, SC Yang, JY Fang International Journal of Molecular Sciences 20 (10), 2558	2019
Use of IL-23 inhibitors for the treatment of plaque psoriasis and psoriatic arthritis: a comprehensive review K Yang, ASW Oak, BE Elewski American Journal of Clinical Dermatology 22, 173-192	2021
Metabolic pathways that control skin homeostasis and inflammation D Cibrian, H de la Fuente, F Sánchez-Madrid Trends in molecular medicine 26 (11), 975-986	2020
Advances in the pathogenesis of psoriasis: From keratinocyte perspective X Zhou, Y Chen, L Cui, Y Shi, C Guo Cell death & disease 13 (1), 81	2022
Psoriasis: obesity and fatty acids M Kunz, JC Simon, A Saalbach Frontiers in immunology 10, 1807	2019
Anti IL-17 in psoriasis K Ly, MP Smith, Q Thibodeaux, V Reddy, W Liao, T Bhutani Expert review of clinical immunology 15 (11), 1185-1194	2019
Topical, systemic and biologic therapies in hidradenitis suppurativa: pathogenic insights by examining therapeutic mechanisms JW Frew, JE Hawkes, JG Krueger Therapeutic Advances in Chronic Disease 10, 2040622319830646	2019
Anticytokine immune therapy and atherothrombotic cardiovascular risk H Ait-Oufella, P Libby, A Tedgui Arteriosclerosis, thrombosis, and vascular biology 39 (8), 1510-1519	2019
T helper 17 cells as pathogenic drivers of periodontitis N Dutzan, L Abusleme Oral mucosal immunity and microbiome, 107-117	2019
Soluble ligands as drug targets MM Attwood, J Jonsson, M Rask-Andersen, HB Schiöth Nature Reviews Drug Discovery 19 (10), 695-710	2020
Significance of IL-17A-producing CD8+ CD103+ skin resident memory T cells in psoriasis lesion and their possible relationship to clinical course K Kurihara, T Fujiyama, P Phadungsaksawasdi, T Ito, Y Tokura Journal of Dermatological Science 95 (1), 21-27	2019
Differential changes in inflammatory mononuclear phagocyte and T-cell profiles within psoriatic skin during treatment with guselkumab vs. secukinumab H Mehta, S Mashiko, J Angsana, M Rubio, YCM Hsieh, C Maari, K Reich, ... Journal of Investigative Dermatology 141 (7), 1707-1718. e9	2021
Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies MT Patrick, H Zhang, R Wasikowski, EP Prens, S Weidinger, ... Journal of Allergy and Clinical Immunology 147 (3), 857-869. e7	2021

1 - 20

计算机程序会自动估算并确定日期和引用次数。